As claimed by CNBC, “In 2012, Sanofi agreed to pay for the federal federal government $109 million to solve allegations that the organization violated the False Statements Act by providing physicians free models of the knee injection Hyalgan to be able to induce them to obtain and prescribe the drug, in violation from the Anti-Kickback Statut